This Proposal will study the hypothesis that pharmacodynamic studies of whole extracts of tumor specimens of patients treated with 5-FU plus pure (/)-leucovorin will be improved by our newly-developed methods for quantitative histopathology. Our biochemical data suggest that the goals of 5-FU/leucovorin therapy are decreases in intratumoral thymidylate synthase (TS) and expansion of H4PteGlu pools. Tumors of patients with breast and gastrointestinal cancer will be biopsied before and after 5- FU(/)-leucovorin therapy and at tumor progression. Equal hemi-cylinder tumor biopsies will be taken for surgical pathology and for tissue homogenization assays of TS, tetrahydrofolate, 5,10- methylenetetrahydrofolate, dUMP, and FdUMP, by established [3H]FdUMP ligand-binding assays, and for TS mRNA by the Danenberg assay. TS protein will also be quantitated by ELISA assay using a rabbit polyclonal anti- human TS antibody preparation. Pathology studies of 4-micron sections will include immunoperoxidase antibody staining for TS, nuclear staining for cell counts, common-leukocyte-antigen staining for white cells, and Ki 67 staining for S-phase and growth fraction determination. Initial studies will include comparison of fresh frozen vs. paraffin-embedded tissues. The antibodies used for TS immunostaining may also enable visualization of H4PteGlun and 5,10-CH2-H4PteGlun pools, by forming TS-FdUMP-folate ternary complexes in situ, using exogenous TS addition. Quantitation of the numbers, intensities, and areas of immunostaining will be done by digital image analysis using video microscopy and JAVA software; a novel method for validation of this approach will sue common-embedding of reference cells in the specimen blocks for same-frame calibration of parameters. Double- labeling, such as immunofluorescence combined with immunoperoxidase staining for TS will permit quantitation of TS antigen levels by cell type. In addition, the image analysis system should be useful for quantitation of cells visualized by in situ mRNA hybridization of transcripts of interest.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA039629-09
Application #
2089894
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1985-05-01
Project End
1996-06-30
Budget Start
1994-07-01
Budget End
1996-06-30
Support Year
9
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Southern California
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Salonga, D; Danenberg, K D; Johnson, M et al. (2000) Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin Cancer Res 6:1322-7
Odin, E; Carlsson, G; Frosing, R et al. (1998) Chemical stability and human plasma pharmacokinetics of reduced folates. Cancer Invest 16:447-55
Metzger, R; Danenberg, K; Leichman, C G et al. (1998) High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil. Clin Cancer Res 4:2371-6
Carlsson, G; Hafstrom, L O; Spears, C P et al. (1997) 5-fluorouracil (5-FU) and 5,10-methylene tetrahydrofolate (5,10-CH2FH4) as adjuvant therapy in an experimental rodent colon carcinoma model. Anticancer Res 17:3671-4
Leichman, C G; Lenz, H J; Leichman, L et al. (1997) Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. J Clin Oncol 15:3223-9
Larsson, P A; Carlsson, G; Gustavsson, B et al. (1996) Thymidylate synthase in advanced gastrointestinal and breast cancers. Acta Oncol 35:469-72
Carlsson, G; Larsson, P A; Frosing, R et al. (1995) 5-Fluorouracil sensitive adenocarcinoma--a new experimental model in the rat. Anticancer Res 15:433-9
Spears, C P (1995) Clinical resistance to antimetabolites. Hematol Oncol Clin North Am 9:397-413
Carlsson, G; Gustavsson, B; Frosing, R et al. (1995) Antitumour effects of pure diastereoisomers of 5-formyltetrahydrofolate in hepatic transplants of a rodent colon carcinoma model. Biochem Pharmacol 50:1347-51
Leichman, L; Lenz, H J; Leichman, C G et al. (1995) Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: preliminary report from an ongoing trial. Eur J Cancer 31A:1306-10

Showing the most recent 10 out of 17 publications